BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16002046)

  • 1. Vascular endothelial growth factor impairs the functional ability of dendritic cells through Id pathways.
    Laxmanan S; Robertson SW; Wang E; Lau JS; Briscoe DM; Mukhopadhyay D
    Biochem Biophys Res Commun; 2005 Aug; 334(1):193-198. PubMed ID: 16002046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells.
    Oyama T; Ran S; Ishida T; Nadaf S; Kerr L; Carbone DP; Gabrilovich DI
    J Immunol; 1998 Feb; 160(3):1224-32. PubMed ID: 9570538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation.
    Dikov MM; Ohm JE; Ray N; Tchekneva EE; Burlison J; Moghanaki D; Nadaf S; Carbone DP
    J Immunol; 2005 Jan; 174(1):215-22. PubMed ID: 15611243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo.
    Ohm JE; Shurin MR; Esche C; Lotze MT; Carbone DP; Gabrilovich DI
    J Immunol; 1999 Sep; 163(6):3260-8. PubMed ID: 10477595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function.
    Gabrilovich DI; Ishida T; Nadaf S; Ohm JE; Carbone DP
    Clin Cancer Res; 1999 Oct; 5(10):2963-70. PubMed ID: 10537366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor (VEGF) impairs the motility and immune function of human mature dendritic cells through the VEGF receptor 2-RhoA-cofilin1 pathway.
    Long J; Hu Z; Xue H; Wang Y; Chen J; Tang F; Zhou J; Liu L; Qiu W; Zhang S; Ouyang Y; Ye Y; Xu G; Li L; Zeng Z
    Cancer Sci; 2019 Aug; 110(8):2357-2367. PubMed ID: 31169331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development.
    Aspord C; Pedroza-Gonzalez A; Gallegos M; Tindle S; Burton EC; Su D; Marches F; Banchereau J; Palucka AK
    J Exp Med; 2007 May; 204(5):1037-47. PubMed ID: 17438063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function.
    Heine A; Held SA; Daecke SN; Riethausen K; Kotthoff P; Flores C; Kurts C; Brossart P
    PLoS One; 2015; 10(6):e0128897. PubMed ID: 26042424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor inhibits the function of human mature dendritic cells mediated by VEGF receptor-2.
    Mimura K; Kono K; Takahashi A; Kawaguchi Y; Fujii H
    Cancer Immunol Immunother; 2007 Jun; 56(6):761-70. PubMed ID: 17086423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual role of VEGF family members in the pathogenesis of head and neck cancer (HNSCC): possible link between angiogenesis and immune tolerance.
    Strauss L; Volland D; Kunkel M; Reichert TE
    Med Sci Monit; 2005 Aug; 11(8):BR280-92. PubMed ID: 16049374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo.
    Gabrilovich D; Ishida T; Oyama T; Ran S; Kravtsov V; Nadaf S; Carbone DP
    Blood; 1998 Dec; 92(11):4150-66. PubMed ID: 9834220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor effects on nuclear factor-kappaB activation in hematopoietic progenitor cells.
    Dikov MM; Oyama T; Cheng P; Takahashi T; Takahashi K; Sepetavec T; Edwards B; Adachi Y; Nadaf S; Daniel T; Gabrilovich DI; Carbone DP
    Cancer Res; 2001 Mar; 61(5):2015-21. PubMed ID: 11280761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells can turn CD4+ T lymphocytes into vascular endothelial growth factor-carrying cells by intercellular neuropilin-1 transfer.
    Bourbié-Vaudaine S; Blanchard N; Hivroz C; Roméo PH
    J Immunol; 2006 Aug; 177(3):1460-9. PubMed ID: 16849452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-frequency ultrasound-induced VEGF suppression and synergy with dendritic cell-mediated anti-tumor immunity in murine prostate cancer cells in vitro.
    Zhang W; Shou WD; Xu YJ; Bai WK; Hu B
    Sci Rep; 2017 Jul; 7(1):5778. PubMed ID: 28720900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting STAT5 by the BET bromodomain inhibitor JQ1 disrupts human dendritic cell maturation.
    Toniolo PA; Liu S; Yeh JE; Moraes-Vieira PM; Walker SR; Vafaizadeh V; Barbuto JA; Frank DA
    J Immunol; 2015 Apr; 194(7):3180-90. PubMed ID: 25725100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biophysical Properties and Motility of Human Mature Dendritic Cells Deteriorated by Vascular Endothelial Growth Factor through Cytoskeleton Remodeling.
    Hu ZQ; Xue H; Long JH; Wang Y; Jia Y; Qiu W; Zhou J; Wen ZY; Yao WJ; Zeng Z
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27809226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-P-selectin lectin-EGF domain monoclonal antibody inhibits the maturation of human immature dendritic cells.
    Zhou T; Zhang Y; Sun G; Zhang Y; Zhang D; Zhao Y; Chen N
    Exp Mol Pathol; 2006 Apr; 80(2):171-6. PubMed ID: 16413535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor-A enhances indoleamine 2,3-dioxygenase expression by dendritic cells and subsequently impacts lymphocyte proliferation.
    Marti LC; Pavon L; Severino P; Sibov T; Guilhen D; Moreira-Filho CA
    Mem Inst Oswaldo Cruz; 2014 Feb; 109(1):70-9. PubMed ID: 24141959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
    Li B; Lalani AS; Harding TC; Luan B; Koprivnikar K; Huan Tu G; Prell R; VanRoey MJ; Simmons AD; Jooss K
    Clin Cancer Res; 2006 Nov; 12(22):6808-16. PubMed ID: 17121902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma-derived factors alter the maturation and activation of differentiated tissue-resident dendritic cells.
    Hargadon KM; Bishop JD; Brandt JP; Hand ZC; Ararso YT; Forrest OA
    Immunol Cell Biol; 2016 Jan; 94(1):24-38. PubMed ID: 26010746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.